on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies Releases Half-Year Liquidity Contract Report
DBV Technologies, a clinical-stage biopharmaceutical firm, disclosed its half-year report regarding the liquidity contract with ODDO BHF. As of June 30, 2025, the liquidity account held 210,069 shares of DBV Technologies and €171,301.08.
Comparatively, when the contract was initiated on July 1, 2018, the account contained 41,159 shares and €432,367.25. From January 1 to June 30, 2025, the company executed 2,204 buy transactions and 2,398 sales transactions, totaling 1,156,109 shares purchased and 1,212,908 shares sold.
The financial operations amounted to €1,492,280.33 in purchases and €1,556,651.52 in sales. This liquidity contract is integral to supporting DBV's market activities, ensuring manageable trading volumes for its stocks.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news